TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Eden Research ( (GB:EDEN) ) is now available.
Eden Research plc announced that its biofungicide 3LOGY has received approval in Italy for use on additional crops and diseases, expanding its application beyond grapes to include legumes, avocados, carrots, and more. This label extension significantly increases 3LOGY’s market reach in Italy by over twenty thousand hectares, enhancing its role in sustainable agriculture and strengthening Eden’s competitive position in the fungicide market.
The most recent analyst rating on (GB:EDEN) stock is a Hold with a £2.00 price target. To see the full list of analyst forecasts on Eden Research stock, see the GB:EDEN Stock Forecast page.
Spark’s Take on GB:EDEN Stock
According to Spark, TipRanks’ AI Analyst, GB:EDEN is a Neutral.
Eden Research’s overall stock score is primarily impacted by its financial performance and technical analysis. The company’s revenue growth is overshadowed by profitability and cash flow challenges. Technical indicators suggest bearish momentum, and valuation metrics highlight significant financial difficulties.
To see Spark’s full report on GB:EDEN stock, click here.
More about Eden Research
Eden Research plc is a UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health, and consumer products industries. Eden’s products are formulated with terpene active ingredients, primarily used on high-value fruits and vegetables, and include Mevalone®, Cedroz™, and EcovelexÔ.
Average Trading Volume: 393,644
Technical Sentiment Signal: Sell
Current Market Cap: £11.73M
Learn more about EDEN stock on TipRanks’ Stock Analysis page.